Miomera

Miomera is a direct-to-consumer skin-care label that sells clinical-grade serums, peptide creams, LED tools and refillable moisturizers. Price span runs mid-range: single serums $38-$68, device bundles $120-$190. Everything is sold only through miomera.com and its Amazon storefront; no brick-and-mortar stockists. The brand formulates in U.S. FDA-registered labs, publishes ingredient percentages on every label, and batches in <500-unit runs to keep freshness dates under six months. Its best-known SKU is the 2 % “Encapsulated Retinol + GABA Overnight Serum,” cited in multiple Reddit skincare threads for visible line-softening within three weeks. All formulas are fragrance-free, pregnancy-safe screened, and shipped in aluminum airless pumps that accept mailed-back refills for a $5 credit. Core buyers are 25-45-year-old professionals who track skincare with spreadsheets, value ingredient transparency over influencer hype, and will pay extra for small-batch stability. They are typically optimizing existing routines rather than chasing 10-step regimens, and they favor brands that disclose lab assays and offer carbon-neutral shipping. Miomera competes with dermatologist-founded cosmeceutical lines and tech-infused skincare startups. It undercuts prestige clinic prices by 30-40 % while keeping actives at prescription-adjacent levels, and counters mass-device brands by bundling free virtual consults and personalized dosing calendars with every tool.